Exparel 133 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DX23FTKZS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $8,443
Award facts
- Contract value 100% obligated
- $8,442.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency, via its Medical Supply Chain division, issued a $8,442.96 delivery order to DMS Pharmaceutical Group Inc. on August 4, 2023, for EXPAREL 133 mg/10 ml vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).
DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. Ultimate completion date is August 25, 2023. The order is priced firm fixed-price with no set-aside designation.
Quick answers
Who was awarded contract SPE2DX23FTKZS?
SPE2DX23FTKZS was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 4, 2023.
How much is contract SPE2DX23FTKZS worth?
The government has obligated $8,443 on SPE2DX23FTKZS.
Is contract SPE2DX23FTKZS an order under another contract?
Yes. SPE2DX23FTKZS is a delivery order under SPE2DX15D9113, an indefinite delivery contract.
Was contract SPE2DX23FTKZS competed?
The extent of competition for SPE2DX23FTKZS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award